RxDoctor Payments Data

John Lazar, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Washington, DCNPI 1578756722

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Johnson & Johnson at 45.7% of the total. Reporting peaked in 2022 at $31,247 and has fallen 67.7% since, to $10,104 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,405in general payments, 2019–2025

Across 227 payments — averaging $349.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$36K
  • Intuitive Surgical$14K
  • Ethicon Endo-surgery Inc.$11K
  • Medtronic$6K
  • AstraZeneca$6K
  • Davol Inc.$2K
  • plus $4K from 16 others
$140,409in research payments, 2019–2025

Across 16 payments — averaging $8775.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$79K
  • Intuitive Surgical Operations, Inc.$60K
  • Veran Medical Technologies, Inc.$1K

What the payments were for

  • Consulting fees$41,54552%
  • Speaking & faculty fees$9,08411%
  • Travel & lodging$18,20623%
  • Food & beverage$8,52511%
  • Education$2,0303%
  • Gifts$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)54$36,285
Intuitive Surgical97$14,193
Ethicon Endo-surgery Inc.6$11,370
Medtronic15$5,822
AstraZeneca6$5,693
Davol Inc.11$1,565
Veran Medical Technologies, Inc.5$1,377
Olympus America Inc.7$921
On Target Laboratories, Inc4$455
Asensus Surgical, Inc.3$448
Pinnacle Biologics, Inc3$275
Genentech, Inc.2$185
Noah Medical Corporation1$162
Abbott1$148
Boston Scientific1$132
Auris Health, Inc.3$111
Atricure, Inc.2$59
BD1$52
ERBE USA Inc1$50
Covidien LP1$41
Galvanize Therapeutics, Inc1$34
Arthrex2$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,405 in reported general payments places this provider in the 95th percentile of 25 thoracic surgery (cardiothoracic vascular surgery) providers in District of Columbia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in District of Columbia

Medicare billing

Part B allowed, 2024
$92,829
Medicare patients
128
Services billed
275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →